{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T18:18:32Z","timestamp":1790619512162,"version":"4.1.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,9,7]],"date-time":"2019-09-07T00:00:00Z","timestamp":1567814400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,9,7]],"date-time":"2019-09-07T00:00:00Z","timestamp":1567814400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13256-019-2213-6","type":"journal-article","created":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T23:03:12Z","timestamp":1567810992000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["The first report of molecular characterized BRD4-NUT carcinoma in Brazil: a case report"],"prefix":"10.1186","volume":"13","author":[{"given":"Leandro J. C.","family":"Oliveira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline B. L.","family":"Gongora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcela T.","family":"Latancia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe G.","family":"Barbosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o Vitor A. M.","family":"Gregorio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo A.","family":"Testagrossa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariane T.","family":"Amano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olavo","family":"Feher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,7]]},"reference":[{"issue":"3","key":"2213_CR1","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/nrc3659","volume":"14","author":"C French","year":"2014","unstructured":"French C. NUT midline carcinoma. Nat Rev Cancer. 2014;14(3):149\u201350.","journal-title":"Nat Rev Cancer"},{"issue":"8","key":"2213_CR2","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1158\/2159-8290.CD-14-0014","volume":"4","author":"CA French","year":"2014","unstructured":"French CA, et al. NSD3-NUT fusion oncoprotein in NUT midline carcinoma: implications for a novel oncogenic mechanism. Cancer Discov. 2014;4(8):928\u201341.","journal-title":"Cancer Discov"},{"issue":"5","key":"2213_CR3","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.prp.2014.10.013","volume":"211","author":"S Suzuki","year":"2015","unstructured":"Suzuki S, et al. NSD3-NUT-expressing midline carcinoma of the lung: first characterization of primary cancer tissue. Pathol Res Pract. 2015;211(5):404\u20138.","journal-title":"Pathol Res Pract"},{"key":"2213_CR4","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1146\/annurev-pathol-011811-132438","volume":"7","author":"CA French","year":"2012","unstructured":"French CA. Pathogenesis of NUT midline carcinoma. Annu Rev Pathol. 2012;7:247\u201365.","journal-title":"Annu Rev Pathol"},{"issue":"1","key":"2213_CR5","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s12105-010-0235-x","volume":"5","author":"EB Stelow","year":"2011","unstructured":"Stelow EB. A review of NUT midline carcinoma. Head Neck Pathol. 2011;5(1):31\u20135.","journal-title":"Head Neck Pathol"},{"issue":"23","key":"2213_CR6","doi-asserted-by":"publisher","first-page":"3632","DOI":"10.1002\/cncr.30242","volume":"122","author":"NG Chau","year":"2016","unstructured":"Chau NG, et al. Intensive treatment and survival outcomes in NUT midline carcinoma of the head and neck. Cancer. 2016;122(23):3632\u201340.","journal-title":"Cancer"},{"issue":"1","key":"2213_CR7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s12105-013-0428-1","volume":"7","author":"CA French","year":"2013","unstructured":"French CA. The importance of diagnosing NUT midline carcinoma. Head Neck Pathol. 2013;7(1):11\u20136.","journal-title":"Head Neck Pathol"},{"issue":"4","key":"2213_CR8","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1097\/PAI.0b013e3182a4ef2e","volume":"22","author":"PG Salles","year":"2014","unstructured":"Salles PG, et al. Expression of P16 in NUT carcinomas with no association with human papillomavirus (HPV). Appl Immunohistochem Mol Morphol. 2014;22(4):262\u20135.","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"2213_CR9","doi-asserted-by":"publisher","first-page":"4135","DOI":"10.1200\/JCO.2004.02.107","volume":"22","author":"CA French","year":"2004","unstructured":"French CA, Kutok JL, Faquin WC, et al. Midline carcinoma of children and young adults with NUT rearrangement. J Clin Oncol. 2004;22:4135\u20139.","journal-title":"J Clin Oncol"},{"issue":"suppl","key":"2213_CR10","doi-asserted-by":"publisher","first-page":"6085","DOI":"10.1200\/JCO.2018.36.15_suppl.6085","volume":"36","author":"NG Chau","year":"2018","unstructured":"Chau NG, Ma C, Danga K, et al. A novel prognostic risk classification model for NUT midline carcinoma: A largest cohort analysis from the NMC registry. J Clin Oncol. 2018;36(suppl):6085.","journal-title":"J Clin Oncol"},{"key":"2213_CR11","volume-title":"Estimate\/2018 \u2013 Cancer Incidence in Brazil (Rio de Janeiro)","author":"Minist\u00e9rio da Saude, Instituto Nacional de C\u00e2ncer Jos\u00e9 Alencar Gomes da Silva","year":"2017","unstructured":"Minist\u00e9rio da Saude, Instituto Nacional de C\u00e2ncer Jos\u00e9 Alencar Gomes da Silva. Estimate\/2018 \u2013 Cancer Incidence in Brazil (Rio de Janeiro), 2017. ISBN 978\u201385\u20137318-361-0."},{"issue":"20","key":"2213_CR12","doi-asserted-by":"publisher","first-page":"5773","DOI":"10.1158\/1078-0432.CCR-12-1153","volume":"18","author":"DE Bauer","year":"2012","unstructured":"Bauer DE, et al. Clinicopathologic features and long-term outcomes of NUT midline carcinoma. Clin Cancer Res. 2012;18(20):5773\u20139.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"2213_CR13","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1007\/s00405-018-4882-y","volume":"275","author":"Prashanth Giridhar","year":"2018","unstructured":"Giridhar P, Mallick S, Kashyap L, Rath GK. Patterns of care and impact of prognostic factors in the outcome of NUT midline carcinoma: a systematic review and individual patient data analysis of 119 cases. Eur Arch Otorhinolaryngol. 2018;275(3):815\u201321.","journal-title":"European Archives of Oto-Rhino-Laryngology"},{"issue":"11","key":"2213_CR14","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1111\/pin.12727","volume":"68","author":"CA French","year":"2018","unstructured":"French CA. NUT Carcinoma: Clinicopathologic features, pathogenesis, and treatment. Pathol Int. 2018;68(11):583\u201395.","journal-title":"Pathol Int"},{"key":"2213_CR15","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1101\/gad.267583.115","volume":"29","author":"AA Alekseyenko","year":"2015","unstructured":"Alekseyenko AA, Walsh EM, Wang X, et al. The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains. Genes Dev. 2015;29:1507\u201323.","journal-title":"Genes Dev"},{"key":"2213_CR16","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1038\/onc.2013.126","volume":"33","author":"AR Grayson","year":"2014","unstructured":"Grayson AR, Walsh EM, Cameron MJ, et al. MYC, a downstream target of BRD-NUT, is necessary and sufficient for the blockade of differentiation in NUT midline carcinoma. Oncogene. 2014;33:1736\u201342.","journal-title":"Oncogene"},{"key":"2213_CR17","doi-asserted-by":"publisher","first-page":"2943","DOI":"10.1038\/emboj.2010.176","volume":"29","author":"N Reynoird","year":"2010","unstructured":"Reynoird N, Schwartz BE, Delvecchio M, et al. Oncogenesis by sequestration of CBP\/p300 in transcriptionally inactive hyperacetylated chromatin domains. EMBOJ. 2010;29:2943\u201352.","journal-title":"EMBOJ"},{"key":"2213_CR18","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1097\/PAS.0b013e318258f03b","volume":"36","author":"AG Evans","year":"2012","unstructured":"Evans AG, French CA, Cameron MJ, et al. Pathologic characteristics of NUT midline carcinoma arising in the mediastinum. Am J Surg Pathol. 2012;36:1222\u20137.","journal-title":"Am J Surg Pathol"},{"key":"2213_CR19","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1097\/PAS.0b013e318198d666","volume":"33","author":"H Haack","year":"2009","unstructured":"Haack H, Johnson LA, Fry CJ, et al. Diagnosis of NUT midline carcinoma using a NUT-specific monoclonal antibody. Am J Surg Pathol. 2009;33:984\u201391.","journal-title":"Am J Surg Pathol"},{"issue":"30","key":"2213_CR20","doi-asserted-by":"publisher","first-page":"3007","DOI":"10.1200\/JCO.2018.78.2292","volume":"36","author":"J Lewin","year":"2018","unstructured":"Lewin J, Soria JC, Stathis A, et al. Phase Ib trial with birabresib, a small molecule inhibitor of bromodomain and extraterminal proteins, in patients with selected advanced solid tumors. J Clin Oncol. 2018;36(30):3007\u201314.","journal-title":"J Clin Oncol"},{"key":"2213_CR21","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1016\/S0959-8049(16)32620-X","volume":"69","author":"S Postel-Vinay","year":"2016","unstructured":"Postel-Vinay S, Herbschleb K, Massard C, et al. First-in-human phase I dose escalation study of the Bromodomain and Extra-Terminal motif (BET) inhibitor BAY 1238097 in subjects with advanced malignancies. Eur J Cancer. 2016;69:S7\u20138.","journal-title":"Eur J Cancer"},{"issue":"2","key":"2213_CR22","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1158\/1535-7163.MCT-16-0390","volume":"16","author":"K Sun","year":"2017","unstructured":"Sun K, Atoyan R, Borek MA, et al. Dual HDAC and PI3K inhibitor CUDC-907 downregulates MYC and suppresses growth of MYC-dependent cancers. Mol Cancer Ther. 2017;16(2):285\u201399.","journal-title":"Mol Cancer Ther"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-019-2213-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13256-019-2213-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-019-2213-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,5]],"date-time":"2020-09-05T23:14:05Z","timestamp":1599347645000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-019-2213-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,7]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["2213"],"URL":"https:\/\/doi.org\/10.1186\/s13256-019-2213-6","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,7]]},"assertion":[{"value":"26 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient\u2019s next of kin for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"279"}}